Prognostic value of biomarkers in chronic heart failure with preserved left ventricular ejection fraction

被引：0
|
作者：
Nikiforova, T. A. [1 ]
Shchekochikhin, D. Yu. [1 ]
Kopylov, F. Yu. [1 ]
Syrkin, A. L. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Minist Hlth Russia, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2016年 / 88卷 / 09期
关键词：
chronic heart failure with preserved ejection fraction; natriuretic peptide; galectin-3; urodilatin; C-type natriuretic peptide (CNP); D-type natriuretic peptide; cystatin C; growth- stimulating factor (ST2); FAMILY-MEMBER ST2; CYSTATIN-C; CARDIAC DYSFUNCTION; KIDNEY INJURY; PREVALENCE; MORTALITY; EPIDEMIOLOGY; MOLECULE-1; OUTCOMES; TRENDS;
D O I：
10.17116/terarkh2016889102-105
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The paper reviews major biomarkers for determining the prognosis in patients with chronic heart failure and preserved ejection fraction. It also considers cystatin C, one of the novel and probably the most practically important biomarkers.
引用
收藏
页码：102 / 105
页数：4
相关论文
共 50 条
  • [41] Management of heart failure patients with preserved left ventricular ejection fraction
    Cohen-Solal, A
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2005, 6 : S15 - S16
  • [42] Heart failure in patients with preserved and deteriorated left ventricular ejection fraction
    Varela-Roman, A
    Grigorian, L
    Barge, E
    Bassante, P
    de la Peña, MG
    Gonzalez-Juanatey, JR
    [J]. HEART, 2005, 91 (04) : 489 - 494
  • [43] Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction
    Santos, Angela B. S.
    Kraigher-Krainer, Elisabeth
    Bello, Natalie
    Claggett, Brian
    Zile, Michael R.
    Pieske, Burkert
    Voors, Adriaan A.
    McMurray, John J. V.
    Packer, Milton
    Bransford, Toni
    Lefkowitz, Marty
    Shah, Amil M.
    Solomon, Scott D.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (01) : 42 - 47
  • [44] Prognostic value of right and left heart functional parameters and levels of biomarkers in chronic heart failure patients with preserved, mid-ranged and reduced ejection fraction
    Tumasyan, L. R. Liana
    Adamyan, K. G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 238 - 239
  • [45] Prognostic value of BNP in heart failure with preserved or reduced ejection fraction
    Bosseau, Christian
    Galli, Elena
    Donal, Erwan
    [J]. HEART, 2015, 101 (23) : 1855 - 1856
  • [46] Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction
    Bazaeva, E. V.
    Myasnikov, R. P.
    Metelskaya, V. A.
    Boytsov, S. A.
    [J]. KARDIOLOGIYA, 2017, 57 (03) : 39 - 45
  • [47] Prognostic Value of Ventilatory Power In Heart Failure with Preserved Ejection Fraction
    Giverts, Ilya
    Poltavskaya, Maria
    Serova, Maria
    Dikur, Oxana
    Kuzmina, Ekaterina
    Suchkova, Svetlana
    Syrkin, Abram
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S115 - S115
  • [48] Prognostic value of echocardiography and ECG in heart failure with preserved ejection fraction
    Cenkerova, K.
    Dubrava, J.
    Pokorna, V
    Kaluzay, J.
    Jurkovicova, O.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (07): : 407 - 412
  • [49] SPECIFIC FEATURES OF PHARMACOTHERAPY OF PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION
    Larina, V. N.
    Leonova, M., V
    Chukaeva, I. I.
    Karpenko, D. G.
    [J]. KARDIOLOGIYA, 2018, 58 (03) : 84 - 93
  • [50] Diastolic stress echocardiography and biomarkers in patients with preserved left ventricular ejection fraction and heart failure symptoms
    Kubicius, Andrzej
    Balys, Mariusz
    Ciampi, Quirino
    Picano, Eugenio
    Gasior, Zbigniew
    Haberka, Maciej
    [J]. KARDIOLOGIA POLSKA, 2022, 80 (05) : 560 - 566
12345